Literature DB >> 26446771

Trabecular bone score as a skeletal fragility index in acromegaly patients.

A R Hong1, J H Kim1, S W Kim1, S Y Kim1, C S Shin2.   

Abstract

SUMMARY: Lumbar spine trabecular bone score (TBS) was significantly decreased in active acromegaly patients. TBS may be useful to assess the skeletal fragility in acromegaly in which bone mineral density (BMD) is not sufficient to represent bone strength and explain the high incidence of fragility fractures in acromegaly patients.
INTRODUCTION: Although the data on BMD are controversial, patients with acromegaly have an increased risk of fragility fracture. We examined the lumbar spine TBS to explain the skeletal deterioration in acromegaly patients.
METHODS: We included 14 men and 19 women acromegaly patients who underwent dual-energy X-ray absorptiometry at the time of diagnosis from 2000 to 2014 at Seoul National University Hospital. Ninety-nine age-, sex- and body mass index-matched controls were recruited. Biochemical parameters, lumbar spine TBS, and BMD at all sites were measured. Gonadal status was evaluated at diagnosis.
RESULTS: Lumbar spine TBS was lower in acromegaly patients than in controls in both genders (1.345 ± 0.121 vs. 1.427 ± 0.087, P = 0.005 in men; 1.356 ± 0.082 vs. 1.431 ± 0.071, P = 0.001 in women). In contrast, BMD at all sites did not differ between the two groups. Hypogonadal acromegaly patients (men, n = 9; women, n = 12) had lower TBS values compared with controls both in men and women (all P < 0.05), although BMD at all sites were similar for the two groups. In eugonadal acromegaly patients, lumbar spine TBS was lower than in women controls only (P = 0.041).
CONCLUSIONS: Skeletal microarchitecture was deteriorated in acromegaly patients as assessed by TBS, which seems to be a consequence of growth hormone excess as well as hypogonadism, especially in women.

Entities:  

Keywords:  Acromegaly; Bone mineral density; Skeletal fragility; Trabecular bone score

Mesh:

Year:  2015        PMID: 26446771     DOI: 10.1007/s00198-015-3344-2

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  34 in total

1.  Bone mineral density and turnover in patients with acromegaly in relation to sex, disease activity, and gonadal function.

Authors:  Marek Bolanowski; Jacek Daroszewski; Marek Medraś; Beata Zadrozna-Sliwka
Journal:  J Bone Miner Metab       Date:  2006       Impact factor: 2.626

2.  The influence of growth hormone deficiency, growth hormone replacement therapy, and other aspects of hypopituitarism on fracture rate and bone mineral density. .

Authors:  C Wüster; R Abs; B A Bengtsson; H Bennmarker; U Feldt-Rasmussen; E Hernberg-Ståhl; J P Monson; B Westberg; P Wilton
Journal:  J Bone Miner Res       Date:  2001-02       Impact factor: 6.741

Review 3.  Trabecular bone score (TBS): available knowledge, clinical relevance, and future prospects.

Authors:  V Bousson; C Bergot; B Sutter; P Levitz; B Cortet
Journal:  Osteoporos Int       Date:  2011-11-15       Impact factor: 4.507

Review 4.  Influence of growth hormone on accretion of bone mass.

Authors:  J P Monson; W M Drake; P V Carroll; J U Weaver; J Rodriguez-Arnao; M O Savage
Journal:  Horm Res       Date:  2002

5.  Relationship of age to bone microstructure independent of areal bone mineral density.

Authors:  Kristy M Nicks; Shreyasee Amin; Elizabeth J Atkinson; B Lawrence Riggs; L Joseph Melton; Sundeep Khosla
Journal:  J Bone Miner Res       Date:  2012-03       Impact factor: 6.741

6.  In acromegaly, increased bone mineral density (BMD) is determined by GH-excess, gonadal function and gender.

Authors:  Wojciech Zgliczynski; Magdalena Kochman; Waldemar Misiorowski; Piotr Zdunowski
Journal:  Neuro Endocrinol Lett       Date:  2007-10       Impact factor: 0.765

Review 7.  Acquisition of bone mass in normal individuals and in patients with growth hormone deficiency.

Authors:  Giampiero I Baroncelli; Silvano Bertelloni; Federica Sodini; Giuseppe Saggese
Journal:  J Pediatr Endocrinol Metab       Date:  2003-03       Impact factor: 1.634

Review 8.  Guidelines for acromegaly management: an update.

Authors:  S Melmed; A Colao; A Barkan; M Molitch; A B Grossman; D Kleinberg; D Clemmons; P Chanson; E Laws; J Schlechte; M L Vance; K Ho; A Giustina
Journal:  J Clin Endocrinol Metab       Date:  2009-02-10       Impact factor: 5.958

9.  Effects of Exemestane and Tamoxifen treatment on bone texture analysis assessed by TBS in comparison with bone mineral density assessed by DXA in women with breast cancer.

Authors:  Matthias Kalder; Didier Hans; Ioannis Kyvernitakis; Olivier Lamy; Martina Bauer; Peyman Hadji
Journal:  J Clin Densitom       Date:  2013-04-03       Impact factor: 2.617

10.  Factors associated with bone metabolism in acromegalic patients: hypogonadism and female gender.

Authors:  N B Tütüncü; T Erbaş
Journal:  Exp Clin Endocrinol Diabetes       Date:  2004-06       Impact factor: 2.949

View more
  14 in total

1.  Epicardial fat is a negative predictor of spine volumetric bone mineral density and trabecular bone score in acromegaly.

Authors:  Elena Valassi; Iris Crespo; Jorge Malouf; David Vilades; Ruben Leta; Jaume Llauger; Eulàlia Urgell; Anna Aulinas; Ana Maria Marín; Betina Biagetti; Susan M Webb
Journal:  Endocrine       Date:  2016-04-07       Impact factor: 3.633

Review 2.  Acromegalic osteopathy.

Authors:  G Mazziotti; F Maffezzoni; S Frara; A Giustina
Journal:  Pituitary       Date:  2017-02       Impact factor: 4.107

Review 3.  Determinants of skeletal fragility in acromegaly: a systematic review and meta-analysis.

Authors:  Cláudia Ribeiro de Moura; Sara Campos Lopes; Ana Margarida Monteiro
Journal:  Pituitary       Date:  2022-07-22       Impact factor: 3.599

4.  Vertebral fractures, trabecular bone score and their determinants in chronic hypoparathyroidism.

Authors:  S Saha; V Mannar; D Kandasamy; V Sreenivas; R Goswami
Journal:  J Endocrinol Invest       Date:  2022-05-19       Impact factor: 5.467

5.  Bone histomorphometry in acromegaly patients with fragility vertebral fractures.

Authors:  L Dalle Carbonare; V Micheletti; E Cosaro; M T Valenti; M Mottes; G Francia; M V Davì
Journal:  Pituitary       Date:  2018-02       Impact factor: 4.107

6.  High-resolution-cone beam tomography analysis of bone microarchitecture in patients with acromegaly and radiological vertebral fractures.

Authors:  Filippo Maffezzoni; Michele Maddalo; Stefano Frara; Monica Mezzone; Ivan Zorza; Fabio Baruffaldi; Francesco Doglietto; Gherardo Mazziotti; Roberto Maroldi; Andrea Giustina
Journal:  Endocrine       Date:  2016-09-06       Impact factor: 3.633

7.  Trabecular bone score and bone mineral density in acromegalic osteopathy assessment: a cross-sectional study.

Authors:  Madalina Cristina Sorohan; Roxana Dusceac; Bogdan Marian Sorohan; Andra Caragheorgheopol; Catalina Poiana
Journal:  Arch Osteoporos       Date:  2021-09-16       Impact factor: 2.617

8.  Measurements of Bone Health after Thyroid-Stimulating Suppression Therapy in Postmenopausal Women with Differentiated Thyroid Carcinoma: Bone Mineral Density versus the Trabecular Bone Score.

Authors:  Chae Won Chung; Hoon Sung Choi; Sung Hye Kong; Young Joo Park; Do Joon Park; Hwa Young Ahn; Sun Wook Cho
Journal:  J Clin Med       Date:  2021-05-03       Impact factor: 4.241

9.  Spine Bone Texture Assessed by Trabecular Bone Score in Active and Controlled Acromegaly: A Prospective Study.

Authors:  E Sala; E Malchiodi; G Carosi; E Verrua; E Cairoli; E Ferrante; M Filopanti; C Eller-Vainicher; F M Ulivieri; A Spada; M Arosio; I Chiodini; G Mantovani
Journal:  J Endocr Soc       Date:  2021-05-15

10.  Application of the Trabecular Bone Score in Clinical Practice.

Authors:  Sung Hye Kong; Namki Hong; Jin-Woo Kim; Deog Yoon Kim; Jung Hee Kim
Journal:  J Bone Metab       Date:  2021-05-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.